Vitamin D and cardiometabolic disorders

Area of Science:

• Cardiology
• Endocrinology
• Nutritional Science

Background:

• Emerging evidence links vitamin D status to cardiometabolic disorder development and severity.
• Low vitamin D levels are associated with higher cardiovascular event risk and poorer outcomes post-event.
• Vitamin D deficiency and insufficiency are globally prevalent, affecting over a billion people.

Purpose of the Study:

• To review recent advances in understanding the relationship between vitamin D status and cardiometabolic disorders.
• To highlight the role of vitamin D in the incidence, prevalence, and pathogenesis of common cardiometabolic conditions.

Main Methods:

• Review of recent clinical and experimental studies.
• Analysis of observational data linking vitamin D levels to cardiovascular outcomes.
• Consideration of ongoing randomized controlled trials evaluating vitamin D supplementation.

Main Results:

• Low vitamin D status is associated with increased risk of major cardiovascular events.
• Suboptimal vitamin D levels may worsen prognosis following cardiovascular events.
• Significant global prevalence of vitamin D deficiency underscores the potential public health impact.

Conclusions:

• Vitamin D status is a significant factor in cardiometabolic health.
• Further research, including supplementation trials, is crucial to establish causality and therapeutic potential.
• Addressing vitamin D deficiency may be important for managing cardiometabolic disorders.